Skip to main content

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Efectos de la administración de albúmina en pacientes cirròticos con encefalopatia hepática

IP: Joan Genescà Ferrer
Collaborators: Meritxell Ventura Cots, Macarena Simon-Talero Horga
Funding agency: Instituto de Salud Carlos III
Funding: 242000
Reference: ICI14/00352
Duration: 01/01/2015 - 30/06/2019

Malalties Hepatobiliars (GRC)

IP: -
Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties Hepatobiliars (GRC), Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Malalties Hepatobiliars (GRC), Malalties Hepatobiliars (GRC), Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 421
Duration: 01/01/2014 - 31/12/2016

Progresión de la hipertensión portal: papel del microbioma intestinal como mediador del efecto de la obesidad

IP: -
Collaborators: Meritxell Ventura Cots, Macarena Simon-Talero Horga
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI14/00331
Duration: 01/01/2015 - 31/12/2017

Recerca clínica i traslacionals de les complicacions de la cirrosi hepàtica

IP: -
Collaborators: Meritxell Ventura Cots
Funding agency: Instituto de Salud Carlos III
Funding: 72000
Reference: CM11/00171
Duration: 03/01/2012 - 02/01/2014

Related news

The results, published in The Lancet and Nature Medicine, provide new evidence to improve the diagnosis of metabolic dysfunction-associated steatotic liver disease and reduce the need for liver biopsies.

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The grants support projects led by Drs. María José Buzón, María Buti, Elena Élez, and Maria Vieito.

Related professionals

Adriana Martinez Cifuentes

Adriana Martinez Cifuentes

Predoctoral researcher
Translational Molecular Pathology
Read more
Juan Carlos Cruz Llobregat

Juan Carlos Cruz Llobregat

Gestió i Administració
External Strategy Directorate
Read more
Silvia Mora Marco

Silvia Mora Marco

Research assistant
Cardiovascular Diseases
Read more
Sandra Gelabert Saurí

Sandra Gelabert Saurí

Research assistant
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.